For the study, published by the New England Journal of Medicine on Monday (March 8), researchers at Pfizer, BioNTech and the University of Texas Medical Branch...
In the phase 2 trial, the Bharat Biotech-ICMR’s COVID-19 vaccine showed better reactogenicity and safety outcomes, and enhanced humoral and cell-mediated immune responses compared with the...
Covaxin is one of the two COVID-19 vaccines to have got emergency use license in India and is being used in India’s vaccination programme
Covishield, a locally manufactured version by Pune’s Serum Institute of India and the indigenous Covaxin, from the Hyderabad-based company Bharat Biotech are the two COVID-19 vaccines...
The first interim analysis is based on 43 cases, of which 36 cases of COVID-19 were observed in the placebo group versus seven cases observed in...
People above 60 and those over 45 with comorbidities began getting their vaccines from March 1 in the second phase of vaccination drive, that is estimated...
Johnson & Johnson's COVID-19 vaccine is different from the other two already on the market- Pfizer/BioNTech and Moderna as it is to be administered in a...
Johnson & Johnson’s COVID-19 vaccine does not need to be kept in a freezer and can be stored at refrigerated temperatures, said CDC’s Director Rochelle Walensky
Those above 45 years of age will require a signed medical certificate, which will attest to the severity of their illness in order for the to qualify...
According to the pharma company Pfizer, it will be testing how well the antibodies produced by its vaccine are able to neutralise some strains of coronavirus
The second phase of the coronavirus vaccination drive in India will begin March 1, with priority given to people over 60 and those over 45 with...
Information and Broadcasting Minister Prakash Javadekar on Wednesday (February 24) announced that people above 60 years and above 45 years with co-morbidities will be vaccinated from...